Anti-apoptotic and anti-inflammatory effects of Silybum marianum in treatment of experimental steatohepatitis
- 30 September 2011
- journal article
- Published by Elsevier BV in Experimental and Toxicologic Pathology
- Vol. 63 (6), 569-574
- https://doi.org/10.1016/j.etp.2010.04.009
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategiesThe Esophagus, 2008
- The JNK signal transduction pathwayCurrent Opinion in Cell Biology, 2007
- Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in ratsChemico-Biological Interactions, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseJournal of Hepatology, 2005
- Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatmentBest Practice & Research Clinical Gastroenterology, 2004
- Apoptosis: The nexus of liver injury and fibrosisJournal of Hepatology, 2004
- A central role for JNK in obesity and insulin resistanceNature, 2002
- Cellular response to oxidative stress: Signaling for suicide and survival*Journal of Cellular Physiology, 2002
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998
- Bromobenzene-Induced Liver Necrosis. Protective Role of Glutathione and Evidence for 3,4-Bromobenzene Oxide as the Hepatotoxic MetabolitePharmacology, 1974